Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
5.06
+0.22 (4.55%)
At close: May 23, 2025, 4:00 PM
5.25
+0.19 (3.75%)
After-hours: May 23, 2025, 4:37 PM EDT
Silence Therapeutics Stock Forecast
SLN's stock price has decreased by -78.21% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 5 professional analysts, the 12-month price target for Silence Therapeutics stock ranges from a low of $3.00 to a high of $75. The average analyst price target of $32.6 forecasts a 544.27% increase in the stock price over the next year.
Price Target: $32.60 (+544.27%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Silence Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Buy | 2 | 2 | 1 | 2 | 2 | 2 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 1 | 1 | 1 | 1 |
Total | 4 | 4 | 4 | 5 | 5 | 5 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Goldman Sachs | Goldman Sachs | Strong Sell Maintains $4 → $3 | Strong Sell | Maintains | $4 → $3 | -40.71% | May 9, 2025 |
Morgan Stanley | Morgan Stanley | Buy Maintains $45 → $25 | Buy | Maintains | $45 → $25 | +394.07% | May 9, 2025 |
Chardan Capital | Chardan Capital | Strong Buy Maintains $55 → $35 | Strong Buy | Maintains | $55 → $35 | +591.70% | May 9, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $75 | Strong Buy | Reiterates | $75 | +1,382.21% | Mar 7, 2025 |
Morgan Stanley | Morgan Stanley | Buy Maintains $49 → $45 | Buy | Maintains | $49 → $45 | +789.33% | Mar 5, 2025 |
Financial Forecast
Revenue This Year
32.34M
from 43.26M
Decreased by -25.23%
Revenue Next Year
n/a
from 32.34M
EPS This Year
n/a
from -0.98
EPS Next Year
n/a
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 |
---|---|
High | 74.5M |
Avg | 32.3M |
Low | 10.3M |
Revenue Growth
Revenue Growth | 2025 |
---|---|
High | 72.2% |
Avg | -25.2% |
Low | -76.3% |
EPS Forecast
EPS |
---|
High |
Avg |
Low |
EPS Growth
EPS Growth |
---|
High |
Avg |
Low |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.